SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-086437
Filing Date
2009-04-24
Accepted
2009-04-24 09:03:49
Documents
4
Effectiveness Date
2009-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 23419
2 GRAPHIC g58568g25c17.jpg GRAPHIC 201490
3 GRAPHIC g58568g44x10.jpg GRAPHIC 58083
4 GRAPHIC g58568g56f82.jpg GRAPHIC 126948
  Complete submission text file 0001193125-09-086437.txt   557913
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 09768047
SIC: 2836 Biological Products, (No Diagnostic Substances)